The C.A.M. Report
Complementary and Alternative Medicine: Fair, Balanced, and to the Point
  • About this web log

    This blog ran from 2006 to 2016 and was intended as an objective and dispassionate source of information on the latest CAM research. Since my background is in pharmacy and allopathic medicine, I view all CAM as advancing through the development pipeline to eventually become integrated into mainstream medical practice. Some will succeed while others fail. But all are treated fairly here.

  • About the author

    John Russo, Jr., PharmD, is president of The MedCom Resource, Inc. Previously, he was senior vice president of medical communications at, a complementary and alternative medicine website.

  • Common sense considerations

    The material on this weblog is for informational purposes. It is not medical advice or counsel. Be smart, consult your health professional before using CAM.

  • Recent Posts

  • Recent Comments

    Biggest losers in CAM for 2007

    We’re talking about companies that manufacture, market, and sell adulterated “Natural” dietary supplements that are promoted to treat impotence. These unscrupulous individuals place unsuspecting users at risk of serious side effects.

    Let’s shine light on the culprits in 2007.

    • Bodee LLC, Inc. issued a nationwide recall of Encore Tabs.
    • America True Man Health recalled it’s True Man?s Sexual Energy Nutriment Men?s Formula.
    • Health Canada advised consumers not to use PJ. Air Madu‘s product called Urat Madu.
    • Jen-On Herbal Science International, Inc. issued a nationwide recall of HS Joy of Love.
    • Barodon SF issued a nationwide recall of V.MAX.
    • FDA announced that more of the Ebek, Inc. product called Liviro3 was discovered after voluntary recall.

    The bottom line?
    In a recent article, Dr. Wayne Hellstrom at Tulane University School of Medicine in New Orleans stated “Studies have found sildenafil [Viagra], sildenafil analogs, tadalafil [Cialis], and tadalafil analogs together in the same supplement.”

    He continues, “These medications pose a particular risk for interactions as they contain combinations of different medications … for which no clinical trials have been performed and no toxicologic profile is available.”

    Consumers and healthcare professionals need to be made aware of this ongoing problem with these losers.

    12/19/07 22:23 JR

    Leave a Comment

    You must be logged in to post a comment.